LIVERPOOL - A 1-day multidisciplinary 'super clinic' set up to treat patients with a diagnosis of mycosis fungoides cutaneous T-cell lymphoma (MF-CTCL) was featured as a possible model for future care ...

Cutaneous T cell lymphomas (CTCL) represent a heterogeneous group of T-cell malignancies that manifest primarily in the skin. By far the most common variant of CTCL is mycosis fungoides and its ...

First English-language case study shows resolution of lesions with 308-nm Excimer laser in rare mycosis fungoides (MF) subtype, poikilodermatous mycosis fungiodes (pMF), underscoring the Company’s ...

Lacutamab is a first-in-class anti-KIR3DL2 humanized cytotoxicity-inducing antibody that is currently in clinical trials for treatment of cutaneous T-cell lymphoma (CTCL), an orphan disease, and ...

View all available purchase options and get full access to this article. The following represents disclosure information provided by authors of this manuscript. All relationships are considered ...

MARSEILLE, France--(BUSINESS WIRE)--Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) announced favorable results from the Phase 2 TELLOMAK study with ...

Mycosis fungoides, an uncommon cutaneous T cell lymphoma, which produces plaques which are the result of the accumulation of the malignant T cells in the upper dermis. The link between head and neck ...

Plaque psoriasis, also known as psoriasis vulgaris, is quite common. The condition affects approximately 1% to 2% of whites, usually presenting in the third to fourth decade of life. Men with mycosis ...

Please provide your email address to receive an email when new articles are posted on . Patients treated with topical hypericin and phototherapy did not experience QT interval variations or heart rate ...